These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3579985)
1. Micro-vacuolation in rat brains after long term administration of GABA-transaminase inhibitors. Comparison of effects of ethanolamine-O-sulphate and vigabatrin. John RA; Rimmer EM; Williams J; Cole G; Fowler LJ; Richens A Biochem Pharmacol; 1987 May; 36(9):1467-73. PubMed ID: 3579985 [TBL] [Abstract][Full Text] [Related]
2. A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats. Butler WH; Ford GP; Newberne JW Toxicol Pathol; 1987; 15(2):143-8. PubMed ID: 3616399 [TBL] [Abstract][Full Text] [Related]
4. Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain. Sidhu RS; Del Bigio MR; Tuor UI; Seshia SS Exp Neurol; 1997 Apr; 144(2):400-5. PubMed ID: 9168839 [TBL] [Abstract][Full Text] [Related]
5. Pharmacology of vigabatrin. Sabers A; Gram L Pharmacol Toxicol; 1992 Apr; 70(4):237-43. PubMed ID: 1608908 [TBL] [Abstract][Full Text] [Related]
6. The effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl-GABA and ethanolamine-O-sulphate on the in vivo release of GABA from rat hippocampus. Qume M; Whitton PS; Fowler LJ J Neurochem; 1995 May; 64(5):2256-61. PubMed ID: 7722510 [TBL] [Abstract][Full Text] [Related]
8. Effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl GABA and ethanolamine O-sulphate on the in vitro GABA release from rat hippocampus. Qume M; Fowler LJ Br J Pharmacol; 1997 Oct; 122(3):539-45. PubMed ID: 9351512 [TBL] [Abstract][Full Text] [Related]
10. Relationship between platelet and brain GABA transaminase inhibition by single and multiple doses of vigabatrin in rats. Valdizán EM; Armijo JA Epilepsia; 1991; 32(5):735-42. PubMed ID: 1915185 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, brain uptake, and pharmacological properties of a glyceryl lipid containing GABA and the GABA-T inhibitor gamma-vinyl-GABA. Jacob JN; Hesse GW; Shashoua VE J Med Chem; 1990 Feb; 33(2):733-6. PubMed ID: 2299639 [TBL] [Abstract][Full Text] [Related]
12. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration. Valdizán EM; Armijo JA Biochem Pharmacol; 1992 May; 43(10):2143-50. PubMed ID: 1599502 [TBL] [Abstract][Full Text] [Related]
14. Potential antidepressant properties of subchronic GABA transaminase inhibitors in the forced swimming test in mice. Semba J; Kuroda Y; Takahashi R Neuropsychobiology; 1989; 21(3):152-6. PubMed ID: 2559361 [TBL] [Abstract][Full Text] [Related]
15. Effects of chronic oral treatment with GABA-transaminase inhibitors on the GABA system in brain, liver, kidney, and plasma of the rat. Qume M; Fowler LJ Biochem Pharmacol; 1996 Nov; 52(9):1355-63. PubMed ID: 8937445 [TBL] [Abstract][Full Text] [Related]
16. Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis. Jolkkonen J; Mazurkiewicz M; Lahtinen H; Riekkinen P Eur J Pharmacol; 1992 Dec; 229(2-3):269-72. PubMed ID: 1490526 [TBL] [Abstract][Full Text] [Related]
17. GABAergic regulation of striatal opioid gene expression. Reimer S; Höllt V Brain Res Mol Brain Res; 1991 Apr; 10(1):49-54. PubMed ID: 1647482 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of GABA, GABA-aminotransferase inhibitors and valproic acid following systemic administration in rats, cats and dogs: pharmacological approach to localize the site of action. Löscher W Arch Int Pharmacodyn Ther; 1982 May; 257(1):32-58. PubMed ID: 6810779 [TBL] [Abstract][Full Text] [Related]